Clinical Trials Browser

Phase 1 × NIH × Adenocarcinoma × Clear all

NCT04034238 2023-08-01

Mesothelin-Targeted Immunotoxin LMB-100 in Combination With Tofacitinib in Persons With Previously Treated Pancreatic Adenocarcinoma, Cholangiocarcinoma and Other Mesothelin Expressing Solid Tumors

Phase 1 Completed

19 enrolled 22 charts

Gastrointestinal

Adenocarcinoma, Cholangiocarcinoma

NCT01730118 2022-09-10

Ad/HER2/Neu Dendritic Cell Cancer Vaccine Testing

Phase 1 Completed

33 enrolled 18 charts

Adenocarcinoma, Breast Neoplasms

NCT01441128 2019-12-17

-02341066 and PF-00299804 for Advanced Non-Small Cell Lung Cancer

Phase 1 Terminated

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms, Carcinoma, Large Cell

NCT01437007 2018-08-03

TKM 080301 for Primary or Secondary Liver Cancer

Phase 1 Completed

BreastGastrointestinalGynecologic

Adenocarcinoma, Breast Neoplasms, Disease, Liver Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT01519817 2018-01-29

Cancer Vaccine Targeting Brachyury Protein in Tumors

Phase 1 Completed

34 enrolled 19 charts

Gastrointestinal

Adenocarcinoma, Colonic Neoplasms, Neoplasms

NCT01051934 2017-07-02

A Phase I Trial of SS1 (dsFv) PE38 With Paclitaxel, Carboplatin, and Bevacizumab in Subjects With Unresectable Non-Small Cell Lung Adenocarcinoma

Phase 1 Completed

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00001569 2008-03-04

Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal Carcinomatosis

Phase 1 Completed

Adenocarcinoma, Carcinoma, Peritoneal Neoplasms